Gary Cross

681 total citations
6 papers, 138 citations indexed

About

Gary Cross is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Gary Cross has authored 6 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Gary Cross's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Gary Cross is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Gary Cross collaborates with scholars based in United Kingdom, United States and South Korea. Gary Cross's co-authors include Joseph Barnett, Joseph Jacob, Jin Woo Song, Maria Kokosi, Athol U. Wells, Elisabetta Renzoni, Toby M. Maher, Eun Young Lee, Eun Jin Chae and Dong Soon Kim and has published in prestigious journals such as Lara D. Veeken, EBioMedicine and Respiratory Research.

In The Last Decade

Gary Cross

6 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Cross United Kingdom	4	127	66	33	29	26	6	138
María Luisa Velloso-Feijoó Spain	3	62 0.5×	47 0.7×	23 0.7×	26 0.9×	19 0.7×	5	69
Lloyd L. Liang United States	5	65 0.5×	26 0.4×	12 0.4×	25 0.9×	11 0.4×	8	84
Susanne Webster Australia	8	165 1.3×	61 0.9×	31 0.9×	34 1.2×	5 0.2×	13	180
Liam Galvin United Kingdom	4	104 0.8×	30 0.5×	11 0.3×	11 0.4×	5 0.2×	12	111
Arvind Rajasekaran United Kingdom	3	41 0.3×	23 0.3×	14 0.4×	15 0.5×	14 0.5×	6	55
Patricia Peñacoba Spain	5	28 0.2×	22 0.3×	12 0.4×	11 0.4×	19 0.7×	11	63
Montserrat I. González-Pérez Mexico	4	39 0.3×	11 0.2×	43 1.3×	19 0.7×	9 0.3×	7	65
Anne Sophie Gamez France	6	73 0.6×	27 0.4×	10 0.3×	4 0.1×	5 0.2×	10	99
Maria Kallieri Greece	4	63 0.5×	62 0.9×	7 0.2×	4 0.1×	3 0.1×	22	84
Elena K. Joerns United States	3	35 0.3×	7 0.1×	29 0.9×	17 0.6×	12 0.5×	14	44

Countries citing papers authored by Gary Cross

Since Specialization

Citations

This map shows the geographic impact of Gary Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Cross more than expected).

Fields of papers citing papers by Gary Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Cross. The network helps show where Gary Cross may publish in the future.

Co-authorship network of co-authors of Gary Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Cross. A scholar is included among the top collaborators of Gary Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Cross. Gary Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wells, Athol U., Joseph Jacob, Nicola Sverzellati, et al.. (2024). A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema. Respiratory Research. 25(1). 33–33. 2 indexed citations

2.

Kim, Grace Hyun J., Gary Cross, Joseph Barnett, et al.. (2022). Automated quantification system predicts survival in rheumatoid arthritis-associated interstitial lung disease. Lara D. Veeken. 61(12). 4702–4710. 25 indexed citations

3.

Kim, Grace Hyun J., et al.. (2021). Automated quantification system predict a progressive phenotype in rheumatoid arthritis-associated interstitial lung disease. OA2968–OA2968. 1 indexed citations

4.

Kim, Ho Cheol, Jeong Seok Lee, Eun Young Lee, et al.. (2020). Risk prediction model in rheumatoid arthritis‐associated interstitial lung disease. Respirology. 25(12). 1257–1264. 35 indexed citations

5.

Jacob, Joseph, Jin Woo Song, Gary Cross, et al.. (2018). Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease. EBioMedicine. 28. 303–310. 48 indexed citations

6.

Jacob, Joseph, Brian J. Bartholmai, Srinivasan Rajagopalan, et al.. (2017). Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 23(6). 593–599. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact